STOCK TITAN

AXGN (NASDAQ) Form 144 lists 3,878 shares via Morgan Stanley broker

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AXGN filing: Notice of proposed sale under Rule 144. The form lists 3,878 shares of Common stock with a transaction date shown as 05/07/2026 and Nasdaq as the market. The filing identifies two blocks of restricted stock: 541 shares (03/16/2023) and 3,337 shares (02/01/2024), and names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 sale notice; no new material corporate event.

The filing lists a proposed resale under Rule 144 for Common stock, including two restricted-stock lots dated 03/16/2023 and 02/01/2024. It names a broker-dealer and a Nasdaq market designation.

Cash-flow treatment and the seller's identity beyond the broker are not specified in the excerpt; subsequent filings or trade reports may disclose transactional details.

Shares listed 3,878 shares entry adjacent to broker and market lines in the excerpt
Restricted lot 1 541 shares Restricted Stock dated 03/16/2023
Restricted lot 2 3,337 shares Restricted Stock dated 02/01/2024
Filing date / notice date 05/07/2026 date shown next to market designation
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock financial
"Restricted Stock | Issuer | 541 | 03/16/2023"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Broker‑Dealer financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does AXGN's Form 144 list for shares to be sold?

The Form 144 lists 3,878 shares of Common stock associated with the notice. It also breaks this into 541 shares dated 03/16/2023 and 3,337 shares dated 02/01/2024, indicating restricted‑stock lots referenced in the filing.

Who is the broker for the AXGN sale noted in Form 144?

The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker. The entry includes a New York Plaza address and associates the broker with the proposed transaction paperwork in the excerpt.

Does AXGN's Form 144 state where the shares will trade?

Yes. The excerpt specifies NASDAQ as the market designation for the securities to be sold. The filing lists a date of 05/07/2026 adjacent to the market entry in the excerpt.

Are the shares in AXGN's Form 144 restricted or free trading?

The excerpt identifies the lots as Restricted Stock with dated grant entries of 03/16/2023 and 02/01/2024. The filing therefore references restricted‑stock lots rather than explicitly stating post-sale unrestricted status.